Endra Life Sciences Inc Reports Results For The Quarter Ended In September: Earnings Summary

ENDRA Life Sciences

14/11/2022 22:02

* ENDRA Life Sciences Inc  NDRA.OQ  reported a quarterly
adjusted
loss of 5 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 5 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ENDRA Life Sciences Inc's reported EPS for the quarter was
a
loss of 5 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ENDRA Life Sciences Inc shares had fallen by 28.4% this
quarter and lost 68.3% so far this year.
    * The company reported a quarterly loss of $3.44 million.
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $4.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.05          -0.05          Met
 Jun. 30 2022      -0.05          -0.06          Missed
 Mar. 31 2022      -0.07          -0.07          Met
 Dec. 31 2021      -0.08          -0.08          Met